Functional (Non Ulcer) Dyspepsia Global Clinical Trials Review, H1, 2015

Functional (Non Ulcer) Dyspepsia Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2676CTIDB
  • |
  • Pages: 75
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Functional (Non Ulcer) Dyspepsia Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Functional (Non Ulcer) Dyspepsia Global Clinical Trials Review, H1, 2015" provides data on the Functional (Non Ulcer) Dyspepsia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Functional (Non Ulcer) Dyspepsia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Functional (Non Ulcer) Dyspepsia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Functional (Non Ulcer) Dyspepsia 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Functional (Non Ulcer) Dyspepsia to Gastrointestinal Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Functional (Non Ulcer) Dyspepsia to Gastrointestinal Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Functional (Non Ulcer) Dyspepsia 25

Subjects Recruited Over a Period of Time 27

Clinical Trials by Sponsor Type 28

Prominent Sponsors 29

Top Companies Participating in Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials 30

Prominent Drugs 31

Clinical Trial Profiles 32

Clinical Trial Overview of Top Companies 32

Zeria Pharmaceutical Co Ltd 32

Clinical Trial Overview of Zeria Pharmaceutical Co Ltd 32

Astellas Pharma Inc. 33

Clinical Trial Overview of Astellas Pharma Inc. 33

Actavis plc 34

Clinical Trial Overview of Actavis plc 34

Zydus Cadila Healthcare Limited 35

Clinical Trial Overview of Zydus Cadila Healthcare Limited 35

Ironwood Pharmaceuticals, Inc. 36

Clinical Trial Overview of Ironwood Pharmaceuticals, Inc. 36

Eisai Co., Ltd. 37

Clinical Trial Overview of Eisai Co., Ltd. 37

Dong-A Socio Group 38

Clinical Trial Overview of Dong-A Socio Group 38

Chemo Espana, S.A. 39

Clinical Trial Overview of Chemo Espana, S.A. 39

Aravis Limited 40

Clinical Trial Overview of Aravis Limited 40

Ajinomoto Co., Inc. 41

Clinical Trial Overview of Ajinomoto Co., Inc. 41

Clinical Trial Overview of Top Institutes / Government 42

Chengdu University of Traditional Chinese Medicine 42

Clinical Trial Overview of Chengdu University of Traditional Chinese Medicine 42

Academic Medical Center 43

Clinical Trial Overview of Academic Medical Center 43

Aga Khan University 44

Clinical Trial Overview of Aga Khan University 44

Chiba University 45

Clinical Trial Overview of Chiba University 45

China Academy of Chinese Medical Sciences 46

Clinical Trial Overview of China Academy of Chinese Medical Sciences 46

Chinese University of Hong Kong 47

Clinical Trial Overview of Chinese University of Hong Kong 47

Chung-Ang University Hospital 48

Clinical Trial Overview of Chung-Ang University Hospital 48

Hyogo College Of Medicine 49

Clinical Trial Overview of Hyogo College Of Medicine 49

Keio University 50

Clinical Trial Overview of Keio University 50

Korea Health Industry Development Institute 51

Clinical Trial Overview of Korea Health Industry Development Institute 51

Five Key Clinical Profiles 52

Appendix 73

Abbreviations 73

Definitions 73

Research Methodology 74

Secondary Research 74

About GlobalData 75

Contact Us 75

Disclaimer 75

Source 75

List of Figures

Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Proportion of Functional (Non Ulcer) Dyspepsia to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15

Functional (Non Ulcer) Dyspepsia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Functional (Non Ulcer) Dyspepsia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Functional (Non Ulcer) Dyspepsia to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18

Functional (Non Ulcer) Dyspepsia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Functional (Non Ulcer) Dyspepsia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27

Functional (Non Ulcer) Dyspepsia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31

GlobalData Methodology 74

List of Tables

Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Clinical Trials by Region, 2015* 7

Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Functional (Non Ulcer) Dyspepsia to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15

Functional (Non Ulcer) Dyspepsia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Functional (Non Ulcer) Dyspepsia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Functional (Non Ulcer) Dyspepsia to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18

Functional (Non Ulcer) Dyspepsia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Functional (Non Ulcer) Dyspepsia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25

Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Terminated Clinical Trials, 2015* 26

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27

Functional (Non Ulcer) Dyspepsia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Zeria Pharmaceutical Co Ltd, 2015* 32

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 33

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015* 34

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Zydus Cadila Healthcare Limited, 2015* 35

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ironwood Pharmaceuticals, Inc., 2015* 36

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 37

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Dong-A Socio Group, 2015* 38

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Chemo Espana, S.A., 2015* 39

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Aravis Limited, 2015* 40

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ajinomoto Co., Inc., 2015* 41

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Chengdu University of Traditional Chinese Medicine, 2015* 42

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 43

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Aga Khan University, 2015* 44

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University, 2015* 45

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by China Academy of Chinese Medical Sciences, 2015* 46

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015* 47

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Chung-Ang University Hospital, 2015* 48

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hyogo College Of Medicine, 2015* 49

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University, 2015* 50

Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Korea Health Industry Development Institute, 2015* 51

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Zeria Pharmaceutical Co Ltd

Astellas Pharma Inc.

Actavis plc

Zydus Cadila Healthcare Limited

Ironwood Pharmaceuticals, Inc.

Eisai Co., Ltd.

Dong-A Socio Group

Chemo Espana, S.A.

Aravis Limited

Ajinomoto Co., Inc.

Functional (Non Ulcer) Dyspepsia Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Functional (Non Ulcer) Dyspepsia, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 160875
Site License
USD 5000 INR 321750
Corporate User License
USD 7500 INR 482625

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com